Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 181

Results For "IMI"

4130 News Found

Lupin receives tentative approval from USFDA for Dapagliflozin and Saxagliptin tablets
Drug Approval | January 04, 2024

Lupin receives tentative approval from USFDA for Dapagliflozin and Saxagliptin tablets

Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US


India screens 1 crore+ person for Sickle Cell Disease
Policy | January 03, 2024

India screens 1 crore+ person for Sickle Cell Disease

The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh


Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24
Drug Approval | January 03, 2024

Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24

The company has received five final approvals


Enpro to acquire Advanced Micro Instruments
News | January 02, 2024

Enpro to acquire Advanced Micro Instruments

AMI to become part of Enpro’s Sealing Technologies Segment


Adani and Sirius form JV to digitally transform India's digital economy
Digitisation | December 31, 2023

Adani and Sirius form JV to digitally transform India's digital economy

Sirius JV will be owned 51% by Sirius and 49% by Adani


Qure solidifies its position as innovation powerhouse with 26 patents
Digitisation | December 30, 2023

Qure solidifies its position as innovation powerhouse with 26 patents

Marks remarkable acceleration in innovation using AI technology


Dr. Reddy's Laboratories acquires Preferred A-1 shares of Edity Therapeutics
News | December 30, 2023

Dr. Reddy's Laboratories acquires Preferred A-1 shares of Edity Therapeutics

The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares


Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR
Policy | December 27, 2023

Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR

NEIAFMR to be developed as the national hub for folk medicine


Apollo Hospitals Enterprise reduces stake in Apollo Home Healthcare
News | December 27, 2023

Apollo Hospitals Enterprise reduces stake in Apollo Home Healthcare

AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care


Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2%
Drug Approval | December 27, 2023

Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2%

Loteprednol Etabonate Ophthalmic Suspension, 0.2%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis